• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1488 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2011 Agency for Healthcare Research and Quality (AHRQ) Screening and treatment of subclinical hypothyroidism or hyperthyroidism
2011 Andalusian Health Technology Assessment Area (AETSA) [Prenatal screening for aneuploidy using free fetal DNA in maternal blood. Systematic review of the literature.]
2011 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of the ThinPrep imager® (HologicTM, Inc) for assisted cervical cytology compared with manual reading of liquid based cytology slides?
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Carotid echo doppler for plaque area measurement in cardiovascular risk stratification]
2011 Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: prostate cancer screening using MRI
2011 Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2011 Haute Autorite de sante (HAS) [Albumin (or protein) to creatinine ratios in the diagnosis of chronic kidney disease in adults]
2011 Haute Autorite de sante (HAS) [Biology of haemostasis disorders: lupus anticoagulant detection]
2011 Basque Office for Health Technology Assessment (OSTEBA) [Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fact sheet: Screening for gestational diabetes - rapid report]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for defined speech and language development disorders in children: Appraisal of the KiSS.2 study]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Benefit assessment of HPV test in primary screening for cervical cancer]
2010 NIHR Health Technology Assessment programme Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial
2010 NIHR Health Technology Assessment programme Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer
2010 NIHR Health Technology Assessment programme Cross-trimester repeated measures testing for Down's syndrome screening: an assessment
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Determining optimal intervals for screening and surveillance: using individualized risk estimates to increase cost-effectiveness]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [General ultrasound screening for developmental dysplasia of the hip at three months of age: an implementation study]
2010 The Netherlands Organisation for Health Research and Development (ZonMw) [Predicting efficient implementation and costs; ultrasound screening for developmental dysplasia of the hip]
2010 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Screening information to users: Information on breast cancer screening to users: assessment of current situation and establishment of evidence-based information standards]
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Polymerase chain reaction tests for methicillin-resistant staphylococcus aureus in hospitalized patients: clinical and cost-effectiveness analyses
2010 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany]
2010 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to users on cancer screening in women: assessment of current situation and establishment of evidence-based information standards 2. Information to users on cervical cancer screening]
2010 Medical Advisory Secretariat (MAS) Cancer screening with digital mammography for women at average risk of breast cancer or MRI for women at high risk
2010 NIHR Health Technology Assessment programme Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 NIHR Health Technology Assessment programme Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems
2010 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Detection of high risk human papillomavirus E6 and E7 oncogenes for cervical cancer screening]
2010 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Development of indicators to assess prevention programs for colorectal cancer in high risk populations]
2010 Penn Medicine Center for Evidence-based Practice (CEP) Urine drug screening in chronic pain patients on opioid therapy
2010 HAYES, Inc. Screening, brief intervention, and referral to treatment (SBIRT) for alcohol misuse
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Screening for colorectal cancer Part 1: Screening tests and project design]
2010 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Screening for colorectal cancer Part 2: Health Economic evaluations and development of costs]
2010 Belgian Health Care Knowledge Centre (KCE) Is neonatal screening for cystic fibrosis recommended in Belgium?
2010 Agency for Healthcare Research and Quality (AHRQ) Enhancing use and quality of colorectal cancer screening
2010 Adelaide Health Technology Assessment (AHTA) Screening for lung cancer utilising computed tomography (CT)
2010 Health Council of the Netherlands Gezondheidsraad (GR) Neonatal screening for cystic fibrosis
2010 Health Council of the Netherlands Gezondheidsraad (GR) The 'thousand-dollar genome': an ethical exploration
2010 Health Council of the Netherlands Gezondheidsraad (GR) [Prenatal screening for trisomy 13 and 18]
2010 Institute for Clinical Evaluative Sciences (ICES) Ontario Burden of Infectious Disease Study (ONBOIDS)
2010 Gesundheit Osterreich GmbH (GOeG) [Efficacy and effectiveness of screening for type 2 diabetes]
2010 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Population ultrasound screening for abdominal aortic aneurysms]
2010 Agency for Healthcare Research and Quality (AHRQ) Screening adults for bladder cancer: update of the 2004 evidence review for the U.S. Preventive Services Task Force
2010 Agency for Healthcare Research and Quality (AHRQ) Screening for osteoporosis: systematic review to update the 2002 U.S. Preventive Services Task Force Recommendation
2010 Agency for Healthcare Research and Quality (AHRQ) Screening for depression in adults and older adults in primary care: an updated systematic review
2010 Adelaide Health Technology Assessment (AHTA) Flexible sigmoidoscopy for colorectal cancer screening
2010 Adelaide Health Technology Assessment (AHTA) Velscope for oral cancer screening
2010 Adelaide Health Technology Assessment (AHTA) Targeted screening for cardiovascular risk for all adults between 40-74 years
2010 Andalusian Health Technology Assessment Area (AETSA) [Genetic screening of colorrectal neoplasms through fecal DNA analysis]
2010 HAYES, Inc. Bayley scales of infant (and toddler) development testing (Pearson Education Inc.) for developmental delays in infants
2010 HAYES, Inc. Breast-Specific Gamma Imaging (BSGI) using the Dilon 6800 gamma camera (Dilon Technologies Inc.)
2010 HAYES, Inc. Intraoperative Radiation Therapy (IORT) for colorectal cancer
2010 HAYES, Inc. Peutz-Jeghers Syndrome (PJS)
2010 HAYES, Inc. Routine ultrasound examination in low-risk pregnancy
2010 HAYES, Inc. Screening, brief intervention, and referral to treatment (sbirt) for illicit drug use
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening programs for asymptomatic unruptured intracranial aneurysms: review of clinical effectiveness, cost-effectiveness, and evidence-based guidelines
2010 Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening and post-operative monitoring in adult patients with obstructive sleep apnea: clinical effectiveness and guidelines
2010 Andalusian Health Technology Assessment Area (AETSA) [Serum biomarkers panel for detecting early stage ovarian cancer]
2010 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriate use of diagnostic imaging technologies in primary and secondary care : ultrasonography in breast pathology]
2010 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Vision screening of preschool children]
2010 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Standards for the appropriate use of health technologies: diagnostic colonoscopy ]
2010 Health Sciences Institute in Aragon (IACS) Complications of diabetes. Diabetic Neuropathy
2010 Canary Health Service [Cost-effectiveness analysis of colorectal cancer screening in general population]
2010 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Search update for report S07-01 - Screening for gestational diabetes]
2010 Canary Health Service [Cost-effectiveness analysis of prostate cancer screening with prostate-specific antigen associated or not with digital rectal examination in men aged 50 years and older]
2009 NIHR Health Technology Assessment programme ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
2009 NIHR Health Technology Assessment programme How far does screening women for partner violence in different health care settings meet the UK National Screening Committee criteria for a screening programme in terms of condition, screening method and intervention?
2009 NIHR Health Technology Assessment programme Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice
2009 NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: systematic review of clinical and cost effectiveness, and natural history
2009 The Netherlands Organisation for Health Research and Development (ZonMw) [Effects and costs of a combined screening and treatment program for elderly (aged 75 years and over) with depressive symptoms in general practice]
2009 NIHR Health Technology Assessment programme Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The relevance of the neonatal urine screening for inborn errors of metabolism performed in Quebec]
2009 Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009 Medical Services Advisory Committee (MSAC) Automation-assisted and liquid-based cytology for cervical cancer screening
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Screening mammography for woman aged 40-49: update]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to parents about neonatal screening for inborn errors of metabolism: assessment of current situation and establishment evidence-based information standards]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Lung cancer screening]
2009 NIHR Health Technology Assessment programme How far does screening women for domestic (partner) violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK National Screening Committee criteria
2009 NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Status quo mammography screening: evaluation results from organised programs
2009 Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for recent heavy alcohol use
2009 NIHR Health Technology Assessment programme Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling
2009 HAYES, Inc. Ancillary urinary cytokeratin (CK) tests for bladder cancer screening and detection
2009 HAYES, Inc. Ancillary urinary microsatellite analysis (MA) for bladder cancer screening and detection
2009 NIHR Health Technology Assessment programme Colour vision testing for diabetic retinopathy: a systematic review of diagnostic accuracy and economic evaluation
2009 Medical Advisory Secretariat (MAS) Magnetic resonance (MR) colonography for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Capsule endoscopy for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Flexible sigmoidoscopy for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Fecal occult blood test for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Computed tomographic (CT) colonography for colorectal cancer screening: an evidence-based analysis
2009 Blue Cross Blue Shield Association (BCBS) CT colonography (virtual colonoscopy) for colon cancer screening
2009 Blue Cross Blue Shield Association (BCBS) Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland
2009 Adelaide Health Technology Assessment (AHTA) Cervista HPV 16/18 for the identification of strains of the human papillomavirus associated with cervical cancer
2009 Adelaide Health Technology Assessment (AHTA) New and emerging technologies for breast cancer detection
2009 Adelaide Health Technology Assessment (AHTA) Rapid testing and targeted population screening for Helicobacter pylori
2009 Adelaide Health Technology Assessment (AHTA) Rapid urine test for Chlamydia trachomatis
2009 Adelaide Health Technology Assessment (AHTA) Breast tomosynthesis: a breast cancer screening tool
2009 Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of digital mammography in breast cancer screening]
2009 HAYES, Inc. Breast-specific gamma imaging (BSGI)
2009 HAYES, Inc. Thiopurine S-Methyltransferase (TPMT) genotyping and phenotyping for predicting response to thiopurine drug therapy for Inflammatory Bowel Disease
2009 HAYES, Inc. Microvolt T-Wave Alternans to Identify Risk of Ventricular Arrhythmias and Sudden Cardiac Death